Carpenter CM, Galvin J, Guy M, McGovern BA. Runaway pacemaker in an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol.1998;9:1008-1011.
Kawanishi DT, Brinker JA, Reeves R.
et al. Cumulative hazard analysis of j-wire fracture in the Accufix series
of atrial permanent pacemaker leads. Pacing Clin Electrophysiol.1998;21:2322-2326.
Saksena S. Antiarrhythmic device advisories and recalls: managing an increasingly
vulnerable process. Pacing Clin Electrophysiol.1999;22:950-952.
Silverman BG, Gross TP, Kaczmarek RG, Hamilton P, Hamburger S. The epidemiology of pacemaker implantation in the United States. Public Health Rep.1995;110:42-46.
Lamas GA, Orav EJ, Stambler BS.
et al. Quality of life and clinical outcomes in elderly patients treated with
ventricular pacing as compared with dual-chamber pacing. N Engl J Med.1998;338:1097-1104.
Connolly SJ, Kerr CR, Gent M.
et al. for the Canadian Trial of Physiologic Pacing Investigators. Effects of physiologic pacing versus ventricular pacing on the risk
of stroke and death due to cardiovascular causes. N Engl J Med.2000;342:1385-1391.
Anderson HR, Nielsen JC, Thomsen PE.
et al. Long-term follow-up of patients from a randomised trial of atrial versus
ventricular pacing for sick-sinus-syndrome. Lancet.1997;350:1210-1216.
Saxon LA, Boehmer JP, Hummel J.
et al. for the VIGOR CHF and VENTAK CHF Investigators. Biventricular pacing in patients with congestive heart failure: two
prospective randomized trials. Am J Cardiol.1999;83:120D-123D.
Gras D, Mabo P, Tang T.
et al. Multisite pacing as a supplemental treatment of congestive heart failure:
preliminary results of the Medtronic Inc InSync Study. Pacing Clin Electrophysiol.1998;21:2249-2255.
AntiarrhythmicsnVersus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators
in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med.1997;337:1576-1583.
Connolly SJ, Gent M, Roberts RS.
et al. for the CIDS Investigators. Canadian Implantable Defibrillator Study (CIDS): a randomized trial
of the implantable cardioverter defibrillator against amiodarone. Circulation.2000;101:1297-1302.
Buxton AE, Lee KL, Fisher JD.
et al. for the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with
coronary artery disease. N Engl J Med.1999;341:1882-1890.
Moss AJ, Hall WJ, Cannom DS.
et al. for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implantable defibrillator in patients with
coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med.1996;335:1933-1940.
Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic
drug treatment in cardiac arrest survivors: the Cardiac Arrest Study Hamburg. Am Heart J.1994;127:1139-1144.
Medtronic Product Performance Report: Bradycardia Products. Minneapolis, Minn: Medtronic; 2000.
Medtronic Product Performance Report: Tachyarrhythmia Management. Minneapolis, Minn: Medtronic; 1999.
Guidant Product Performance Report. St Paul, Minn: Guidant Corp; 1999.
Pacesetter Product Performance Report. Sylmar, Calif: St Jude Medical; 1998.
Sulzer Intermedics Product Performance Report. Angleton, Tex: Sulzer Intermedics Inc; 1997.
Telectronics Product Performance Report: An Aid to Patient Management. Englewood, Colo: Telectronics Pacing Systems; 1996.
Levin PJ, Sassouni C. The potential world market for cardiovascular and medical devices. J Invasive Cardiol.1997;9:138-143.
Population Division, Population Projections Branch, US Census Bureau. Annual Population Estimates by Age Group and Sex,
Selected Years From 1990-2000. Washington, DC: US Census Bureau; 2000. Available at: http://www.census.gov. Accessibility verified July 12, 2001.
National Center for Health Statistics. Health, United States, 1993. Hyattsville, Md: Public Health Service; 1994:187-188.
National Hospital Discharge Survey: Annual Summary 1993 Vital Health Stat 13.1995;121:45-48.
National Center for Health Statistics. Health, United States, 1994. Hyattsville, Md: Public Health Service; 1995:185-186.
National Hospital Discharge Survey: Annual Summary 1994. Vital Health Stat 13.1997;128:8-9.
Trends in the health of older Americans: United States 1994. Vital Health Stat 3.1995;30:223-253.
National Center for Health Statistics. Health, United States, 1995. Hyattsville, Md: Public Health Service; 1996:205-206.
National Hospital Discharge Survey: Annual Summary 1995. Vital Health Stat 13.1998;133:41-44.
National Hospital Discharge Survey: Annual Summary 1996. Vital Health Stat 13.1999;140:31-34.
Health, United States 1996-97 and Injury Chartbook. Hyattsville, Md: National Center for Health Statistics; 1997:217-219.
Annual Survey, National Hospital Discharge Survey 1997. Vital Health Stat 13.1999;144:31-33.
Summary: national hospital discharge survey. Adv Data.2000;316:13-16.
Health, United States, 1998, With Socioeconomic Status and Health
Chartbook. Hyattsville, Md: National Center for Health Statistics; 1998:311-313.
Health, United States, 1999, With Health and Aging Chartbook. Hyattsville, Md: National Center for Health Statistics; 1999:255-258.
Higgins SL. Impact of the multicenter automatic defibrillator implantation trial
on implantable cardioverter-defibrillator indication trends. Am J Cardiol.1999;83:79D-82D.
Reynolds DW, Naccarelli GV, Wilber DJ.and the Task Force Writing Committee. NASPE Expert Consensus Statement: physician workforce in cardiac electrophysiology
and pacing. Pacing Clin Electrophysiol.1998;21:1646-1655.
Nanthakumar K, Dorian P, Ham M.
et al. When pacemakers fail: an analysis of clinical presentation and risk
in 120 patients with failed devices. Pacing Clin Electrophysiol.1998;21:87-93.
House of Representatives Ways and Means Committee. Medicare. In: 1996 Green Book. Washington, DC: US
Government Printing Office; 1996. Ways and Means Committee Print 104-14.
Guide to CPT 2000. Bethesda, Md: American College of Cardiology; 2000.
Bureau of Data Management and Strategy. Payment rates: institutional providers; after outlier removed/before
outlier removed (AOR/BOR) tables. Available at: http://www.hcfa.gov/stats/aoborp00.zip.
Accessibility verified July 8, 2001.
Medicare program: changes to the hospital inpatient prospective payment
systems and fiscal year 2001 rates. 65 Federal Register.47054 (2000).
Medicare program: hospital outpatient services: prospective payment
systems. 63 Federal Register.47601 (1998).
Physician fee schedule: payment policies and relative value unit adjustments. 64 Federal Register.59379 (1999).
Tyers GF. FDA recalls: how do pacemaker manufacturers compare? Ann Thorac Surg.1989;48:390-396.
MacGregor DC, Noble EJ, Morrow JD, Scully HE, Covvey HD, Goldman BS. Management of a pacemaker recall. J Thorac Cardiovasc Surg.1977;74:657-667.
Song SL. Bilitch Report: performance of implantable cardiac rhythm management
devices. Pacing Clin Electrophysiol.1994;17:692-708.
Kawanishi DT, Song S, Furman S.
et al. for the Bilitch Registry and STIMAREC. Failure rates of leads, pulse generators, and programmers have not
diminished over the last 20 years: formal monitoring of performance is still
needed. Pacing Clin Electrophysiol.1996;19:1819-1823.
Goldman BS, Newman D, Fraser J, Irwin M. Management of intracardiac device recalls: a consensus conference. Pacing Clin Electrophysiol.1996;19:7-17.
Godin JF, Petitot JC, Pioger G. STIMAREC report: STIMAREC 1996 annual review. Pacing Clin Electrophysiol.1997;20:747-750.
Langewiesche W. Lessons of ValuJet 592. Atlantic Monthly.1998;281:81-98.
Food and Drug Administration. FDA Enforcement Report. Rockville, Md: National Press Office; February 12, 1997.
Food and Drug Administration. FDA Enforcement Report. Rockville, Md: National Press Office; May 5, 1999.
Food and Drug Administration. FDA Enforcement Report. Rockville, Md: National Press Office; December 15, 1999.
Sears Jr SF, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators:
a literature review. Clin Cardiol.1999;22:481-489.
Aydemir O, Ozmen E, Kuey L.
et al. Psychiatric morbidity and depressive symptomatology in patients with
permanent pacemakers. Pacing Clin Electrophysiol.1997;20:1628-1632.
Sneed NV, Finch NJ, Leman RB. The impact of device recall on patients and family members of patients
with automatic implantable cardioverter defibrillators. Heart Lung.1994;23:317-322.
Llewellyn MJ, Bennett DH, Shearer KS, Slaven YM. The impact of manufacturer's revision of pacemaker service life on
the workload of a large pacing center. Pacing Clin Electrophysiol.1989;12:1014-1017.